How to Differentiate Your Pharmaceutical Product in the Personalized Medicine Segment
FARMINGTON, Conn., Sept. 13, 2012 /PRNewswire-iReach/ — Global Information Inc. is pleased to announce a limited time offer on personalized medicine, next generation sequencing (NGS) and epigenetics research from Takeda Pacific, a bio/pharmaceutical and life sciences industry analyst firm based in California.
Personalized Medicine: Companies, Trends and World Market
The Personalized Medicine market includes significant core medical product areas that will continue to have a powerful impact on current and future healthcare delivery. The science driving personalized medicine includes pharmacogenetics, pharmacogenproteomics and pharmacometabalomix. Personalized medicine uses a targeted drug that depends on the patient information identified by a companion diagnostic (genetic biomarker test).
This report examines key market segments such as targeted drugs and key personalized medicine diagnostics, including companion diagnostic IVDs, LDTs, diagnostic services and related tools or technologies. Important technologies examined include: microarray, next-generation sequencing, polymerase chain reaction (PCR), bioinformatics, nanotechnology and other platforms. The report highlights new personalized diagnostics and also covers key biomarkers, commercial diagnostics and therapeutics that drive personalized medicine.
Save up to 20% by purchasing this report before October 15, 2012.
For a detailed executive summary, sample charts, and table of contents, or to request free sample pages from the full report, please visit http://www.giiresearch.com/report/tak238167-personalized-medicine-companies-trends-world.html
Epigenetics: Technologies, Drugs, Diagnostics, and World Market
Many people already know about DNA, genes and the human genome. The DNA code defines the structure of who we are, our potential health and our characteristics that we pass on to our children. Epigenetics refers to the second code of life and links environmental impacts to a person’s health. Epigenetic mechanisms signal how and when genes are activated or silenced.
This research study discusses the market for life science tools and technologies that support epigenetics R&D. The report discusses important technologies, equipment and consumables including microarray, next-generation sequencing, PCR and other platforms. Topics such as microRNA and human stem cells are lightly covered.
This study discusses important epigenetics topics and provides the reader with key findings. The data estimates that the worldwide epigenetics market value will reach multi-billions of dollars in 2010, with a strong double-digit growth rate. This report reviews the activities of 35 companies. The study uses 39 figures and tables to illustrate the findings. This study includes many valuable tables that help the reader scan the details of major trends, market segmentation, forecast, M&As, partnerships, grant funding, patents and so on.
For a detailed executive summary, sample charts, and table of contents, or to request free sample pages from the full report, please visit http://www.giiresearch.com/report/tak127630-epigenetics-diagno.html
Next Generation Sequencing: Opportunities, Trends and World Market
This must-have report discusses the fast-growing worldwide market for next-generation sequencing (NGS) tools and services. Within a short time, the commercial NGS systems have seen a rapid uptake as these systems have been deployed into large genome centers, non-profit institutes, cancer research centers, drug makers, diagnostics firms and service providers worldwide. The report estimates that the total NGS tools and service market will reach $1.3 billion in 2011 and grow at a high double digit growth rate over the next 5-years. The report shows that various NGS systems are available to fill nearly every customer need, from high production volumes, to small scale, or to special niches.
For a detailed executive summary, sample charts, and table of contents, or to request free sample pages from the full report, please visit http://www.giiresearch.com/report/tak192391-next-generation-sequencing-opportunities-trends.html
Save up to 20% by purchasing any of these three reports before October 15, 2012.
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Media Contact: Jeremy Palaia Global Information, Inc.,, 1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.